Last updated: May 26, 2026
Suppliers for Alvaiz (alpelisib): Which companies make the drug substance, fill-finish, and supply active ingredient under US regulatory oversight?
Alvaiz is a brand name for alpelisib (PIQRAY-alpelisib). The US supply chain is typically structured around (1) upstream API manufacturers, (2) drug product (DP) manufacturing and fill-finish, and (3) labeler/market authorization holder functions that are reflected in FDA listings and contracted manufacturing disclosures. However, a supplier map requires specific FDA records (Orange Book, Drug Registration and Listing System, and device-like manufacturing disclosures on labels) tied to the exact NDC(s) for Alvaiz.
No sufficient, citable supplier-identification inputs are provided here to produce a complete and accurate list of API suppliers, DP manufacturers, and fill-finish sites for Alvaiz in the US or specific regions.
Who are the API manufacturers (drug substance) behind Alvaiz alpelisib?
A complete API supplier listing requires alpelisib-to-NDC mapping and then linking each NDC to FDA manufacturing site data and labeler information. Without that dataset, a definitive supplier roster cannot be produced.
What APIs and intermediates are used for alpelisib supply?
Alpelisib supply typically involves controlled synthesis and impurity management consistent with NDA manufacturing controls and ICH Q3A/Q3B frameworks, but specific supplier names must be sourced from FDA manufacturing listings tied to the Alvaiz NDCs.
Which countries typically supply alpelisib API?
This varies by market and contract manufacturing network. Country-of-origin statements must come from FDA and label records for Alvaiz, which are not included in the input.
Which companies do drug product manufacturing and fill-finish for Alvaiz?
Drug product suppliers are identified via NDC labeler and manufacturing site listings. Without the Alvaiz NDC(s) and associated labeler/manufacturer entries, a supplier list would be incomplete.
Are there multiple DP sites for Alvaiz across strengths?
Multi-strength portfolios often use multiple DP lines or sites. That cannot be stated for Alvaiz without NDC-specific manufacturing data.
What does the Orange Book list for Alvaiz suppliers and manufacturers?
Orange Book entries link to NDA and application numbers and sometimes provide manufacturing/patent-coverage context, but supplier identity still requires confirming the specific product (strength/market) and then matching to FDA registration listings. No product-specific Orange Book/NDC data is provided.
What is the FDA NDC labeler/manufacturer structure for Alvaiz?
FDA labeler structure is the fastest way to identify who is accountable in the US supply chain. The required mappings are missing here.
How do I identify fill-finish and packaging responsibility from FDA records?
This is done by matching the NDC labeler to the FDA Drug Registration and Listing entry and then using the listed manufacturing sites for DP. That source linkage is not available in the provided input.
How many suppliers exist for Alvaiz supply in the US?
Supplier count depends on the number of NDCs and registered manufacturing sites for API and DP. Without NDC and site listings, the number cannot be stated accurately.
Which contract manufacturers supply alpelisib-based oncology products like Alvaiz?
Generic alpelisib supply patterns are drug-specific and NDC-specific. A list of likely CMOs would not be sufficient without confirming Alvaiz’s exact manufacturing registrations.
What supplier risks affect availability of Alvaiz (alpelisib)?
Availability risks include single-site DP fill-finish dependence, API impurity specification excursions, and site capacity constraints. Specific risks for Alvaiz require historical FDA inspection outcomes, recall history, and supply chain disruptions for the exact registered sites. No such records are provided.
Key Takeaways
- A supplier map for Alvaiz requires NDC-specific FDA registrations that tie product labeler/manufacturers to API and drug product sites.
- The input contains no Alvaiz NDC(s), no Orange Book/NDA identifiers, and no FDA registration listing data.
- Without those identifiers, an accurate, complete supplier list cannot be produced.
FAQs
- How do I find the Alvaiz labeler on the bottle and map it to FDA registrations?
- What FDA data fields identify API vs drug product manufacturing sites for alpelisib?
- Which Orange Book record fields help trace manufacturing-related product identifiers?
- How do NDC changes signal new DP contract manufacturers for branded oncology drugs?
- What is the fastest compliance workflow to screen Alvaiz supplier substitutions for GMP continuity?
References (APA)
No sources were provided or can be cited from the given input.
